Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, proof-of-principle, open-label study designed to evaluate the
efficacy, safety, and tolerability of MN-001 in non-alcoholic steatohepatitis (NASH) and
Non-Alcoholic Fatty Liver Disease (NAFLD) subjects with hypertriglyceridemia.